Sale!

Hyperthyroid Graves’ Disease Panel Test

950 د.إ

-10%

The Hyperthyroid Graves’ Disease Panel Test is a comprehensive diagnostic tool used to evaluate and diagnose Graves’ disease, an autoimmune disorder that is the most common cause of hyperthyroidism. This condition occurs when the immune system mistakenly attacks the thyroid gland, leading to an overproduction of thyroid hormones. These hormones are crucial for regulating the body’s metabolic rate, and their excess can lead to a wide range of symptoms including weight loss, rapid heartbeat, sweating, and anxiety.

DNA Labs UAE offers this specialized panel test at a cost of 950 AED. The panel typically includes a series of blood tests designed to measure the levels of thyroid-stimulating hormone (TSH), Free T4, Free T3, and the presence of thyroid-stimulating immunoglobulins (TSI) that can indicate Graves’ disease. The test may also check for the presence of other antibodies that could suggest a different autoimmune thyroid condition.

Conducted in a state-of-the-art facility, the Hyperthyroid Graves’ Disease Panel Test at DNA Labs UAE is designed to provide accurate and comprehensive results. These results can help healthcare providers develop an effective treatment plan tailored to the individual’s condition. Early detection and treatment of Graves’ disease are crucial for managing symptoms and preventing complications, making this test an important tool for those experiencing symptoms of hyperthyroidism.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

HYPERTHYROID GRAVES’ DISEASE PANEL Test

Test Cost: AED 950.0

Symptoms Diagnosis:

The Hyperthyroid Graves’ Disease Panel test is a blood test that is used to evaluate and diagnose hyperthyroidism and Graves’ disease. It measures the levels of various hormones and antibodies in the blood that are associated with these conditions.

Test Components:

  • Free T4
  • TSH
  • Total T3
  • TSH Receptor Antibody

Sample Condition: 4 mL (3 mL min.) serum from 1 SST. Ship refrigerated or frozen.

Report Delivery: Sample Daily by 4 pm; Report Same day

Method: CLIA, ECLIA

Test Type: Disorders of Thyroid

Doctor: Endocrinologist, Physician

Test Department:

Pre Test Information: No special preparation required

Test Details:

The Hyperthyroid/Graves’ Disease Panel test is a blood test that is used to evaluate and diagnose hyperthyroidism and Graves’ disease. It measures the levels of various hormones and antibodies in the blood that are associated with these conditions. The panel typically includes the following tests:

  1. Thyroid-stimulating hormone (TSH): This hormone is produced by the pituitary gland and regulates the production of thyroid hormones. In hyperthyroidism, TSH levels are usually low.
  2. Free thyroxine (FT4): This test measures the level of the active form of thyroid hormone in the blood. Elevated FT4 levels are often seen in hyperthyroidism.
  3. Free triiodothyronine (FT3): This test measures the level of another active form of thyroid hormone. Elevated FT3 levels are also seen in hyperthyroidism.
  4. Thyroid peroxidase antibody (TPOAb): This test detects the presence of antibodies that target the thyroid gland. High levels of TPOAb are often found in Graves’ disease.
  5. Thyroid-stimulating immunoglobulin (TSI): This test measures the level of antibodies that mimic the action of TSH, leading to excessive thyroid hormone production. Elevated TSI levels are indicative of Graves’ disease.

By analyzing the results of these tests, healthcare providers can assess thyroid function, determine the cause of hyperthyroidism, and differentiate between Graves’ disease and other causes of hyperthyroidism. It is important to note that this panel is just one tool in the diagnostic process, and additional tests and evaluations may be necessary to confirm a diagnosis and develop an appropriate treatment plan. It is always best to consult with a healthcare professional for a comprehensive evaluation and interpretation of test results.

Test Name HYPERTHYROID GRAVES’ DISEASE PANEL Test
Components *Free T4*TSH*Total T3*TSH Receptor Antibody
Price 950.0 AED
Sample Condition 4 mL ( 3 mL min.) serum from 1 SST. Ship refrigerated or frozen.
Report Delivery Sample Daily by 4 pm; Report Same day
Method CLIA, ECLIA
Test type Disorders of Thyroid
Doctor Endocrinologist, Physician
Test Department:
Pre Test Information No special preparation required
Test Details

The Hyperthyroid/Graves’ Disease Panel test is a blood test that is used to evaluate and diagnose hyperthyroidism and Graves’ disease. It measures the levels of various hormones and antibodies in the blood that are associated with these conditions.

The panel typically includes the following tests:

1. Thyroid-stimulating hormone (TSH): This hormone is produced by the pituitary gland and regulates the production of thyroid hormones. In hyperthyroidism, TSH levels are usually low.

2. Free thyroxine (FT4): This test measures the level of the active form of thyroid hormone in the blood. Elevated FT4 levels are often seen in hyperthyroidism.

3. Free triiodothyronine (FT3): This test measures the level of another active form of thyroid hormone. Elevated FT3 levels are also seen in hyperthyroidism.

4. Thyroid peroxidase antibody (TPOAb): This test detects the presence of antibodies that target the thyroid gland. High levels of TPOAb are often found in Graves’ disease.

5. Thyroid-stimulating immunoglobulin (TSI): This test measures the level of antibodies that mimic the action of TSH, leading to excessive thyroid hormone production. Elevated TSI levels are indicative of Graves’ disease.

By analyzing the results of these tests, healthcare providers can assess thyroid function, determine the cause of hyperthyroidism, and differentiate between Graves’ disease and other causes of hyperthyroidism.

It is important to note that this panel is just one tool in the diagnostic process, and additional tests and evaluations may be necessary to confirm a diagnosis and develop an appropriate treatment plan. It is always best to consult with a healthcare professional for a comprehensive evaluation and interpretation of test results.